| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/27/2000 | WO2000004165A1 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004162A2 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004161A1 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004156A2 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES) |
| 01/27/2000 | WO2000004155A2 Compositions and methods for enhancing disease resistance in plants |
| 01/27/2000 | WO2000004154A2 Genes encoding sulfate assimilation proteins |
| 01/27/2000 | WO2000004152A2 Androgen receptor coactivators |
| 01/27/2000 | WO2000004151A2 Identification and characterization of splice variants of kappa3-related opioid receptor (kor3) gene |
| 01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
| 01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | WO2000004148A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 01/27/2000 | WO2000004147A1 Differentiation regulatory factor expressed specifically in testis |
| 01/27/2000 | WO2000004146A1 A synthetic polynucleotide coding for human lactoferrin, vectors, cells and transgenic plants containing it |
| 01/27/2000 | WO2000004145A2 Myotilin, an actin-organizing protein |
| 01/27/2000 | WO2000004144A1 Snurpotine i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | WO2000004143A1 Mammalian fast transcription factor |
| 01/27/2000 | WO2000004142A1 Mucins |
| 01/27/2000 | WO2000004140A1 71 human secreted proteins |
| 01/27/2000 | WO2000004132A1 Mass production method of lactoferrin polypeptide from yeast and useful microorganism thereof |
| 01/27/2000 | WO2000004052A2 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | WO2000004051A2 Growth differentiation factor promoter and uses therefor |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004048A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 01/27/2000 | WO2000004047A1 Cosmetic compositions for slimming |
| 01/27/2000 | WO2000004046A2 Multiple splice variants of the mu-opioid receptor gene |
| 01/27/2000 | WO2000004045A1 Axor10, a g-protein coupled receptor |
| 01/27/2000 | WO2000004044A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 01/27/2000 | WO2000004043A1 Protease susceptibility ii |
| 01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
| 01/27/2000 | WO2000004040A2 Constitutive disease resistance gene (cdr1), and methods of use thereof |
| 01/27/2000 | WO2000004037A1 Uncoupling protein 4 (ucp-4) and methods of use |
| 01/27/2000 | WO2000004031A1 Phosphorous organic compounds and their use |
| 01/27/2000 | WO2000003732A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 01/27/2000 | WO2000003726A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | WO2000003699A2 Drugs containing phosphoric acid derivatives as active ingredient and their use |
| 01/27/2000 | WO2000003693A1 Survivin, and peptides thereof, as an anti-cancer vaccine |
| 01/27/2000 | WO2000003687A2 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | WO1999064604A3 Attenuated pestiviruses |
| 01/27/2000 | WO1999063086A3 Insulin-like growth factor binding protein-3 variants |
| 01/27/2000 | WO1999063081A3 Ion channels |
| 01/27/2000 | WO1999061639A3 Retroviral delivery system |
| 01/27/2000 | WO1999061630A3 Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system |
| 01/27/2000 | WO1999061595A3 Adeno-associated viral vector-mediated expression of factor viii activity |
| 01/27/2000 | WO1999061589A3 Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/27/2000 | WO1999059609A3 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 01/27/2000 | WO1999058682A3 Compounds from moraxella catarrhalis |
| 01/27/2000 | WO1999058564B1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 01/27/2000 | WO1999057278A3 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
| 01/27/2000 | WO1999055840A8 A transcription factor and method for regulation of seed development, quality and stress-tolerance |
| 01/27/2000 | WO1999054465A9 Gene encoding syntaxin interacting protein |
| 01/27/2000 | WO1999050303A3 Immune response modulator alpha-2 macroglobulin complex |
| 01/27/2000 | WO1999045128A3 Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities |
| 01/27/2000 | WO1998046257A8 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 01/27/2000 | DE19856301C1 Regulatory protein pKe83 from human epidermal keratinocytes and related nucleic acid, vectors and antibodies |
| 01/27/2000 | DE19831637A1 Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis |
| 01/27/2000 | CA2720311A1 A method of producing cells with a desired property by recursive sequence recombination |
| 01/27/2000 | CA2613125A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2337835A1 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | CA2337635A1 Method of making proteins in transformed yeast cells |
| 01/27/2000 | CA2337511A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 01/27/2000 | CA2337231A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | CA2337103A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 01/27/2000 | CA2337096A1 Constitutive disease resistance gene (cdr1), and methods of use thereof |
| 01/27/2000 | CA2336219A1 Identification and characterization of multiple splice variants of the kappa3-related opioid receptor (kor-3) gene |
| 01/27/2000 | CA2336143A1 Aminoalkylphosphonic acid derivatives and their use in treating infections |
| 01/27/2000 | CA2335277A1 Multiple splice variants of the mu-opioid receptor gene |
| 01/27/2000 | CA2335274A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 01/27/2000 | CA2335101A1 Androgen receptor coactivators |
| 01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
| 01/27/2000 | CA2334080A1 Cleavage of caulobacter produced recombinant fusion proteins |
| 01/27/2000 | CA2334075A1 Bone morphogenic protein |
| 01/27/2000 | CA2334039A1 Recombination repair gene, mim, from arabidopsis thaliana |
| 01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2333929A1 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | CA2333917A1 71 human secreted proteins |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2333897A1 Process to collect metabolites from modified nectar by insects |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | CA2333856A1 Serotype-specific probes for listeria monocytogenes |
| 01/27/2000 | CA2333853A1 Mucins |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/26/2000 | EP0974668A1 Use of adenoviral E4 reading frames to improve expression of a gene of interest |
| 01/26/2000 | EP0974667A1 Process to collect metabolites from modified nectar by insects |
| 01/26/2000 | EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme |
| 01/26/2000 | EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy |
| 01/26/2000 | EP0974660A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 01/26/2000 | EP0974659A2 Viral nucleotide sequences |
| 01/26/2000 | EP0974658A1 PROBES FOR THE DIAGNOSIS OF INFECTIONS CAUSED BY $i(STREPTOCOCCUS PYOGENES) |
| 01/26/2000 | EP0974657A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
| 01/26/2000 | EP0974656A1 Dna gyrase inhibitor protein |
| 01/26/2000 | EP0974655A2 G-CSF analog compositions and methods |
| 01/26/2000 | EP0974654A2 Method for secretory production of human growth hormone |
| 01/26/2000 | EP0974653A2 Human gastric cancer antigen gene and protein |
| 01/26/2000 | EP0974651A1 Physiologically active protein originating in mammals |
| 01/26/2000 | EP0974650A1 Endothelial cell growth inhibitors |
| 01/26/2000 | EP0974649A1 Screening system |
| 01/26/2000 | EP0974599A1 Recombinant single-stranded equine chorionic gonadotropin |
| 01/26/2000 | EP0974359A2 FSH and FSH variant formulations, products and methods |
| 01/26/2000 | EP0974111A1 Apparatus and method for automated protein design |